Search - tctmd.com

Displaying 161 - 180 of 690

Sort: Relevancy | Date

News Industry News

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

April 04, 2016

News Industry News

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

April 01, 2016

News Industry News

Aralez Announces FDA Acceptance of New Drug Application for YOSPRALA™

March 28, 2016

News Industry News

STENTYS Announces the CE Marking of the Self-Apposing Stent for Left Main Coronary Artery Disease

March 21, 2016

News Industry News

CorMatrix® Cardiovascular, Inc. Treats First Patient in Its US Clinical Study for CorMatrix® ECM® Tricuspid Valve at Franciscan St. Francis Health Indianapolis, IN

March 17, 2016

News Industry News

Aralez resubmits to FDA New Drug Application for YOSPRALA

March 15, 2016

News Industry News

LivaNova, PLC Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery

March 08, 2016

News Industry News

Endologix Announces First Patients in Japan Treated With Nellix® EndoVascular Aneurysm Sealing System

March 08, 2016

News Industry News

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

March 06, 2016

News Industry News

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

March 01, 2016

News Industry News

LivaNova PLC Receives Regulatory Approval in Japan for the Solo Smart Stentless Tissue Aortic Valve

February 28, 2016

News Industry News

REVA Achieves Target Patient Enrollment in FANTOM II Trial

February 23, 2016

News Industry News

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

February 21, 2016

News Industry News

Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans

February 21, 2016

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

February 04, 2016

News Industry News

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

February 01, 2016

News Industry News

Mast Therapeutics Announces Positive Top-Line Results From Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Conducted At Mayo Clinic

January 31, 2016

News Industry News

LivaNova PLC Announces FDA Approval of Stented Heart Valve CROWN PRT™ for Aortic Valve Disease

January 31, 2016

News Industry News

U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin)

January 24, 2016

News Industry News

Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol

January 21, 2016

Advertisement

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

Aralez Announces FDA Acceptance of New Drug Application for YOSPRALA™

STENTYS Announces the CE Marking of the Self-Apposing Stent for Left Main Coronary Artery Disease

CorMatrix® Cardiovascular, Inc. Treats First Patient in Its US Clinical Study for CorMatrix® ECM® Tricuspid Valve at Franciscan St. Francis Health Indianapolis, IN

Aralez resubmits to FDA New Drug Application for YOSPRALA

LivaNova, PLC Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery

Endologix Announces First Patients in Japan Treated With Nellix® EndoVascular Aneurysm Sealing System

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

New Haven Pharmaceuticals Presents Positive Data That Shows DURLAZA™ is Well Tolerated and Delivers Sustained 24-hour Antiplatelet Control

LivaNova PLC Receives Regulatory Approval in Japan for the Solo Smart Stentless Tissue Aortic Valve

REVA Achieves Target Patient Enrollment in FANTOM II Trial

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

Medtronic Receives CE Mark for Full Line of Cardiac Resynchronization Therapy-Defibrillators Compatible with MRI Scans

Medtronic First to Receive FDA Approval for MR-Conditional Cardiac Resynchronization Therapy-Defibrillators

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

Mast Therapeutics Announces Positive Top-Line Results From Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Conducted At Mayo Clinic

LivaNova PLC Announces FDA Approval of Stented Heart Valve CROWN PRT™ for Aortic Valve Disease

U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin)

Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content